Home Medicine Notes
Chapter
Licensed
Unlicensed Requires Authentication

Notes

View more publications by Rutgers University Press
To Publisher Page
Transformed States
This chapter is in the book Transformed States
247NotesNotes to Preface1.Thomas L. Friedman, Thank You for Being Late: An Optimist’s Guide to Thriving in the Age of Accelerations (New York: Farrar, Straus and Giroux, 2016), 22, 201, 298; “Invest-ment in Biopharma Is Reaching an Inflection Point,” Biospace, September  21, 2021, accessed February 1, 2023, https://www.biospace.com/article/investment-in-biopharma-is-reaching-an-inflection-point-.2.The White House, National Bioeconomy Blueprint, April 2012, https://obamawhitehouse.archives.gov/administration/eop/ostp/library/bioeconomy. For the colors used to characterize different branches of biotechnology see Paweł Kafarski, “Rainbow Code of Biotechnology,” Chemik 66, no. 8 (2012): 811–816.3.John  P. Holdren, Howard Shelanski, Darci Vetter, and Christy Goldfuss, “Improv-ing Transparency and Ensuring Continued Safety in Biotechnology,” July 2, 2015, accessed November  21, 2021, https://obamawhitehouse.archives.gov/blog/2015/07/02/improving-transparency-and-ensuring-continued-safety-biotechnology; President’s Council of Advi-sors on Science and Technology to President Obama, November 2016, accessed Novem-ber  21, 2021, https://obamawhitehouse.archives.gov/sites/default/files/microsites/ostp/PCAST/pcast_biodefense_letter_report_final.pdf. See also Paul Virilio and Sylvère Lotringer, Crepuscular Dawn, trans. Mike Taormina (Cambridge, MA: MIT Press, 2002); and Paul Virilio, The Administration of Fear (New York: Semiotext(e), 2012).4.Achille Mbembe, Necropolitics (Durham, NC: Duke University Press, 2019), 14.5.John Tomlinson, The Culture of Speed: The Coming of Immediacy (London: Sage, 2007), 10.6.See John Pat Leary, “Innovation and the Neoliberal Idioms of Development,” boundary2, August 2018, accessed November 30, 2021, https://www.boundary2.org/2018/0 8/ l e a r y.7.Sherry Turkle, Alone Together: Why We Expect More from Technology and Less from Each Other (New York: Basic Books, 2011), 242–243.8.Virilio, Administration of Fear, 3 7.9.American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disor-ders, 4th ed. (Washington, DC: American Psychiatric Association, 1994), #300.02.10.Substance Abuse and Mental Health Services Administration, Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health (Rockville, MD: Sub-stance Abuse and Mental Health Services Administration, 2016), Table  3.15, accessed October  15, 2021, https://www.ncbi.nlm.nih.gov/books/NBK519704/table/ch3.t15. See
© 2024 Rutgers University Press, New Brunswick

247NotesNotes to Preface1.Thomas L. Friedman, Thank You for Being Late: An Optimist’s Guide to Thriving in the Age of Accelerations (New York: Farrar, Straus and Giroux, 2016), 22, 201, 298; “Invest-ment in Biopharma Is Reaching an Inflection Point,” Biospace, September  21, 2021, accessed February 1, 2023, https://www.biospace.com/article/investment-in-biopharma-is-reaching-an-inflection-point-.2.The White House, National Bioeconomy Blueprint, April 2012, https://obamawhitehouse.archives.gov/administration/eop/ostp/library/bioeconomy. For the colors used to characterize different branches of biotechnology see Paweł Kafarski, “Rainbow Code of Biotechnology,” Chemik 66, no. 8 (2012): 811–816.3.John  P. Holdren, Howard Shelanski, Darci Vetter, and Christy Goldfuss, “Improv-ing Transparency and Ensuring Continued Safety in Biotechnology,” July 2, 2015, accessed November  21, 2021, https://obamawhitehouse.archives.gov/blog/2015/07/02/improving-transparency-and-ensuring-continued-safety-biotechnology; President’s Council of Advi-sors on Science and Technology to President Obama, November 2016, accessed Novem-ber  21, 2021, https://obamawhitehouse.archives.gov/sites/default/files/microsites/ostp/PCAST/pcast_biodefense_letter_report_final.pdf. See also Paul Virilio and Sylvère Lotringer, Crepuscular Dawn, trans. Mike Taormina (Cambridge, MA: MIT Press, 2002); and Paul Virilio, The Administration of Fear (New York: Semiotext(e), 2012).4.Achille Mbembe, Necropolitics (Durham, NC: Duke University Press, 2019), 14.5.John Tomlinson, The Culture of Speed: The Coming of Immediacy (London: Sage, 2007), 10.6.See John Pat Leary, “Innovation and the Neoliberal Idioms of Development,” boundary2, August 2018, accessed November 30, 2021, https://www.boundary2.org/2018/0 8/ l e a r y.7.Sherry Turkle, Alone Together: Why We Expect More from Technology and Less from Each Other (New York: Basic Books, 2011), 242–243.8.Virilio, Administration of Fear, 3 7.9.American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disor-ders, 4th ed. (Washington, DC: American Psychiatric Association, 1994), #300.02.10.Substance Abuse and Mental Health Services Administration, Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health (Rockville, MD: Sub-stance Abuse and Mental Health Services Administration, 2016), Table  3.15, accessed October  15, 2021, https://www.ncbi.nlm.nih.gov/books/NBK519704/table/ch3.t15. See
© 2024 Rutgers University Press, New Brunswick

Chapters in this book

  1. Frontmatter i
  2. Contents vii
  3. List of Illustrations ix
  4. Preface xi
  5. Introduction 1
  6. Part One Genetic States
  7. 1 Genomics, Diversity, and the Millennial Imagination 21
  8. 2 Embryonic Entanglements 47
  9. Part Two Conscious States
  10. 3 Health in the Neuronal Workspace 71
  11. 4 Augmented Lives 98
  12. Part Three Dynamic States
  13. 5 Keeping On 125
  14. 6 Traveling Through 154
  15. Part Four Perilous States
  16. 7 Pandemic Culture 179
  17. 8 Invisible Toxicities 207
  18. Conclusion 235
  19. Acknowledgments 243
  20. Notes 247
  21. Index 351
Readers are also interested in:
https://doi.org/10.36019/9781978817906-014

Chapters in this book

  1. Frontmatter i
  2. Contents vii
  3. List of Illustrations ix
  4. Preface xi
  5. Introduction 1
  6. Part One Genetic States
  7. 1 Genomics, Diversity, and the Millennial Imagination 21
  8. 2 Embryonic Entanglements 47
  9. Part Two Conscious States
  10. 3 Health in the Neuronal Workspace 71
  11. 4 Augmented Lives 98
  12. Part Three Dynamic States
  13. 5 Keeping On 125
  14. 6 Traveling Through 154
  15. Part Four Perilous States
  16. 7 Pandemic Culture 179
  17. 8 Invisible Toxicities 207
  18. Conclusion 235
  19. Acknowledgments 243
  20. Notes 247
  21. Index 351
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 14.11.2025 from https://www.degruyterbrill.com/document/doi/10.36019/9781978817906-014/pdf?licenseType=restricted&srsltid=AfmBOorHRKdswsyfgB5khRkMYa3wnultOxKiJosTerE7l2iI5nKclnVb
Scroll to top button